1. Home
  2. SCNI vs LGHL Comparison

SCNI vs LGHL Comparison

Compare SCNI & LGHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCNI
  • LGHL
  • Stock Information
  • Founded
  • SCNI 2003
  • LGHL 2015
  • Country
  • SCNI Israel
  • LGHL Singapore
  • Employees
  • SCNI N/A
  • LGHL N/A
  • Industry
  • SCNI Biotechnology: Biological Products (No Diagnostic Substances)
  • LGHL Investment Bankers/Brokers/Service
  • Sector
  • SCNI Health Care
  • LGHL Finance
  • Exchange
  • SCNI Nasdaq
  • LGHL Nasdaq
  • Market Cap
  • SCNI 2.0M
  • LGHL 1.8M
  • IPO Year
  • SCNI N/A
  • LGHL N/A
  • Fundamental
  • Price
  • SCNI $1.52
  • LGHL $2.29
  • Analyst Decision
  • SCNI
  • LGHL
  • Analyst Count
  • SCNI 0
  • LGHL 0
  • Target Price
  • SCNI N/A
  • LGHL N/A
  • AVG Volume (30 Days)
  • SCNI 3.0M
  • LGHL 307.2K
  • Earning Date
  • SCNI 08-19-2025
  • LGHL 08-19-2025
  • Dividend Yield
  • SCNI N/A
  • LGHL N/A
  • EPS Growth
  • SCNI N/A
  • LGHL N/A
  • EPS
  • SCNI N/A
  • LGHL N/A
  • Revenue
  • SCNI $658,000.00
  • LGHL N/A
  • Revenue This Year
  • SCNI N/A
  • LGHL N/A
  • Revenue Next Year
  • SCNI N/A
  • LGHL N/A
  • P/E Ratio
  • SCNI N/A
  • LGHL N/A
  • Revenue Growth
  • SCNI N/A
  • LGHL N/A
  • 52 Week Low
  • SCNI $1.40
  • LGHL $2.13
  • 52 Week High
  • SCNI $6.18
  • LGHL $20.86
  • Technical
  • Relative Strength Index (RSI)
  • SCNI 29.96
  • LGHL 39.44
  • Support Level
  • SCNI $1.40
  • LGHL $2.18
  • Resistance Level
  • SCNI $1.64
  • LGHL $2.48
  • Average True Range (ATR)
  • SCNI 0.24
  • LGHL 0.31
  • MACD
  • SCNI -0.03
  • LGHL -0.08
  • Stochastic Oscillator
  • SCNI 5.77
  • LGHL 10.60

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

About LGHL Lion Group Holding Ltd.

Lion Group Holding Ltd is an investor-focused trading platform that offers various products and services. The company's current business lines include total return swap (TRS) trading business, contracts for difference (CFD) trading services, Hong Kong-based Over-The-Counter (OTC) stock options trading business, and futures and securities brokerage services. It provides these services through its Lion Brokers Pro and a variety of other applications. The company generates a majority of its revenue from its CFD trading services business. Geographically, the firm's key revenue-generating market is Hong Kong.

Share on Social Networks: